| Activating ESR1 mutations in hormone-resistant metastatic breast cancer DR Robinson, YM Wu, P Vats, F Su, RJ Lonigro, X Cao, ... Nature genetics 45 (12), 1446-1451, 2013 | 1179 | 2013 |
| Landscape of microsatellite instability across 39 cancer types R Bonneville, MA Krook, EA Kautto, J Miya, MR Wing, HZ Chen, ... JCO precision oncology 1, 1-15, 2017 | 1163 | 2017 |
| Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing DR Robinson, YM Wu, S Kalyana-Sundaram, X Cao, RJ Lonigro, ... Nature genetics 45 (2), 180-185, 2013 | 773 | 2013 |
| Identification of targetable FGFR gene fusions in diverse cancers YM Wu, F Su, S Kalyana-Sundaram, N Khazanov, B Ateeq, X Cao, ... Cancer discovery 3 (6), 636-647, 2013 | 767 | 2013 |
| Personalized oncology through integrative high-throughput sequencing: a pilot study S Roychowdhury, MK Iyer, DR Robinson, RJ Lonigro, YM Wu, X Cao, ... Science translational medicine 3 (111), 111ra121-111ra121, 2011 | 655 | 2011 |
| A human CD34 (+) subset resides in lymph nodes and differentiates into CD56brightNatural killer cells AG Freud, B Becknell, S Roychowdhury, HC Mao, AK Ferketich, ... Immunity 22 (3), 295-304, 2005 | 484 | 2005 |
| Return of genomic results to research participants: the floor, the ceiling, and the choices in between GP Jarvik, LM Amendola, JS Berg, K Brothers, EW Clayton, W Chung, ... The American Journal of Human Genetics 94 (6), 818-826, 2014 | 423 | 2014 |
| Integrative clinical sequencing in the management of refractory or relapsed cancer in youth RJ Mody, YM Wu, RJ Lonigro, X Cao, S Roychowdhury, P Vats, KM Frank, ... Jama 314 (9), 913-925, 2015 | 382 | 2015 |
| Implementing personalized cancer genomics in clinical trials R Simon, S Roychowdhury Nature reviews Drug discovery 12 (5), 358-369, 2013 | 360 | 2013 |
| Evaluation of hybridization capture versus amplicon‐based methods for whole‐exome sequencing E Samorodnitsky, BM Jewell, R Hagopian, J Miya, MR Wing, E Lyon, ... Human mutation 36 (9), 903-914, 2015 | 276 | 2015 |
| Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre … M Javle, S Roychowdhury, RK Kelley, S Sadeghi, T Macarulla, KH Weiss, ... The Lancet Gastroenterology & Hepatology 6 (10), 803-815, 2021 | 259 | 2021 |
| Performance evaluation for rapid detection of pan-cancer microsatellite instability with MANTIS EA Kautto, R Bonneville, J Miya, L Yu, MA Krook, JW Reeser, ... Oncotarget 8 (5), 7452, 2017 | 240 | 2017 |
| Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance MA Krook, JW Reeser, G Ernst, H Barker, M Wilberding, G Li, HZ Chen, ... British Journal of Cancer 124 (5), 880-892, 2021 | 201 | 2021 |
| Translating cancer genomes and transcriptomes for precision oncology S Roychowdhury, AM Chinnaiyan CA: a cancer journal for clinicians 66 (1), 75-88, 2016 | 182 | 2016 |
| Efficacy of FGFR inhibitors and combination therapies for acquired resistance in FGFR2-fusion cholangiocarcinoma MA Krook, A Lenyo, M Wilberding, H Barker, M Dantuono, KM Bailey, ... Molecular cancer therapeutics 19 (3), 847-857, 2020 | 113 | 2020 |
| Advancing precision medicine for prostate cancer through genomics S Roychowdhury, AM Chinnaiyan Journal of Clinical Oncology 31 (15), 1866, 2013 | 111 | 2013 |
| Combination immunotherapy of B-cell non-Hodgkin’s lymphoma with rituximab and interleukin-2: a preclinical and phase I study CF Eisenbeis, A Grainger, B Fischer, RA Baiocchi, L Carrodeguas, ... Clinical cancer research 10 (18), 6101-6110, 2004 | 108 | 2004 |
| Final results from a phase II study of infigratinib (BGJ398), an FGFR-selective tyrosine kinase inhibitor, in patients with previously treated advanced cholangiocarcinoma … MM Javle, S Roychowdhury, RK Kelley, S Sadeghi, T Macarulla, ... Journal of Clinical Oncology 39 (3_suppl), 265-265, 2021 | 105 | 2021 |
| The Bayesian basket design for genomic variant-driven phase II trials R Simon, S Geyer, J Subramanian, S Roychowdhury Seminars in Oncology 43 (1), 13-18, 2016 | 105 | 2016 |
| Identification of targetable FGFR gene fusions in diverse cancers. Cancer Discov. 2013; 3: 636–647. doi: 10.1158/2159-8290 YM Wu, F Su, S Kalyana-Sundaram, N Khazanov, B Ateeq, X Cao, ... CD-13-0050.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 103 | |
